Cargando…
A presumed case of Darbepoetin‐induced myocardial infarction in the patient with MDS‐RARS
Our case is only the 2nd such reported case of atherothrombosis from ESAs and highlights the increased risk of cardiovascular events in patients receiving erythropoietin‐stimulating agents specially patients with underlying MDS where targeting a lower hemoglobin goal and optimizing other cardiovascu...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141713/ https://www.ncbi.nlm.nih.gov/pubmed/32274030 http://dx.doi.org/10.1002/ccr3.2728 |